Srs Capital Advisors, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History

Srs Capital Advisors, Inc.

  • $977 Million
  • Q2 2024

A detailed history of Srs Capital Advisors, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 225 shares of XBI stock, worth $22,068. This represents 0.0% of its overall portfolio holdings.

Number of Shares
225
Previous 225 -0.0%
Holding current value
$22,068
Previous $21,000 4.76%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$87.05 - $102.89 $8,705 - $10,289
-100 Reduced 30.77%
225 $21,000
Q2 2023

Aug 14, 2023
SELL
$75.38 - $90.23 $14,322 - $17,143
-190 Reduced 36.89%
325 $27,000
Q3 2022

Nov 03, 2022
BUY
N/A
515 New
515 $41,000
Q2 2021

Aug 02, 2021
SELL
N/A
-387 Closed
0 $0
Q4 2020

Feb 03, 2021
BUY
N/A
1 Added 0.26%
387 $54,000
Q3 2020

Nov 12, 2020
BUY
N/A
193 Added 100.0%
386 $43,000
Q2 2020

Aug 06, 2020
BUY
N/A
193 New
193 $22,000
Q3 2019

Nov 01, 2019
SELL
N/A
-180 Closed
0 $0
Q2 2019

Aug 08, 2019
SELL
N/A
-71 Reduced 28.29%
180 $16,000
Q3 2018

Nov 06, 2018
BUY
N/A
251 New
251 $24,000

Others Institutions Holding XBI

# of Institutions
894
Shares Held
94.6M
Call Options Held
18.4M
Put Options Held
31.6M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email